Loading issuer details...
Held by NZ managed funds
Sub-substantial fund positions — invisible in NZX SSH data, visible here. Sourced from each fund's Quarterly Fund Update on the FMA Disclose register.
| Fund | % of fund NAV |
|---|---|
| Fisher Funds — New Zealand Growth | 18.39% |
| Mint — Australasian Equity | 17.65% |
| Mint — New Zealand Sri Equity | 17.57% |
| Harbour — Australasian Equity | 16.23% |
| Fisher Funds — Trans Tasman Equity | 9.19% |
+ 3 more funds hold FPH. Full breakdown and coverage
How Fisher & Paykel Healthcare Corporation Limited makes money — FY2025
Revenue $2.0b · EBITDA $649.5m (32.1% of revenue) · Net profit $377.2m (18.7% of revenue)
Band widths are proportional to NZD amounts. Dashed outlines mark derived figures; the hatched node is a balancing item (net profit less every line above it).
| FY2025 | Amount | Status | Note |
|---|---|---|---|
| Revenue | $2.0b | Reported | |
| Operating costs (net of other income) | −$1.4b | Derived * | Reported operating expenses $761.3m do not reconcile; not used. |
| EBITDA | $649.5m | Derived * | |
| Depreciation & amortisation | −$139.9m | Reported | |
| EBIT | $509.6m | Reported | |
| Interest (net finance costs) | −$11.1m | Reported | |
| Income tax | −$126.1m | Reported | |
| Other items (net gain) | +$4.8m | Balancing item * | Net profit less the lines above; covers fair-value movements, impairments, associates and anything else not itemised. |
| Net profit | $377.2m | Reported |
- * ebitda: $649.5m = EBIT + depreciation & amortisation
- * operating costs: $1.4b = Revenue − EBITDA
Figures extracted automatically from the annual report; check against the report. NZD thousands as stored, shown in millions. Source: annual_report_pdf · method: claude_haiku_pdf · extracted 7 March 2026.
Annual report: Fisher & Paykel Healthcare Corporation Limited Annual Report (PDF, NZX)
Fisher & Paykel Healthcare Corporation Limited board of directors
8 current directors, average tenure 5.5 years.
| Director | Role | Independent | Appointed | Tenure | Committees |
|---|---|---|---|---|---|
| Neville Mitchell | Chair | Yes | 2018 | 7.9 yrs | People & Remuneration, Audit & Risk |
| Lewis Gradon | Executive Director | No | 2016 | 10.6 yrs | — |
| Lisa McIntyre | Non-Independent Director | No | 2021 | 5.1 yrs | People & Remuneration |
| Andrew Mark Cross | Independent Director | Yes | 2024 | 2.1 yrs | — |
| Michael Daniell | Independent Director | Yes | 2016 | 10.6 yrs | People & Remuneration |
| Graham McLean | Independent Director | Yes | 2023 | 3.0 yrs | Audit & Risk |
| Cather Simpson | Independent Director | Yes | 2022 | 4.0 yrs | — |
| Anna Curzon | Director | Not recorded | 2026 | 0.7 yrs | — |
Future directors & observers
Non-voting board observers, such as Institute of Directors Future Directors. They are not counted in the board size, independence or governance figures above.
- Margie Apa — Future Director, since 2026
- Claudia Wyss — Future Director, since 2018
- Toni Moyes — Future Director, since 2020
- Charlotte Walshe — Future Director, since 2024
FPH governance score breakdown
Fisher & Paykel Healthcare Corporation Limited scores 84/100 (Excellent) on the NZXplorer Governance Risk Score for FY2026, based on 73% data coverage. See the GRS methodology.
- Board structure
- 22/25
- Shareholder rights
- 20/20
- Executive remuneration
- 3.5/10
FPH dividends
The most recent Fisher & Paykel Healthcare Corporation Limited dividend on record is 33.00 cents per share, for FY2026 (final), 100% imputed, ex-dividend 22 Jun 2026, paid 3 Jul 2026.
Fisher & Paykel Healthcare Corporation Limited largest shareholders
Top 10 registered holders of FPH as disclosed for FY2024. Registry holdings include custodians and nominees, which may hold on behalf of many underlying investors.
| # | Holder | Holding |
|---|---|---|
| 1 | HSBC Nominees (New Zealand) Limited R601127393 | 14.30% |
| 2 | HSBC Nominees (New Zealand) Limited R60112738551 | 8.88% |
| 3 | JPMorgan Nominees Australia Pty Limited | 8.33% |
| 4 | HSBC Custody Nominees (Australia) Limited | 8.22% |
| 5 | JPMorgan Chase Bank | 6.58% |
| 6 | BNP Paribas Nominees NZ Limited | 5.75% |
| 7 | Citicorp Nominees Pty Limited | 4.85% |
| 8 | Citibank Nominees (NZ) Ltd | 4.83% |
| 9 | Custodial Services Limited | 3.55% |
| 10 | Tea Custodians Limited | 3.35% |
Recent FPH NZX announcements
The 10 most recent filings by Fisher & Paykel Healthcare Corporation Limited to the NZX.
- FPH to announce half year results on 26 November 2026Half Year Results
- FPH to sell portion of Karaka Road land in Drury to HNZProperty
- Ongoing Disclosure Notice - Ordinary SharesInsider Disclosure
- Capital Change Notice - North America ESPPCapital Change
- Ongoing Disclosure Notices - Options, PSRs, Ordinary SharesInsider Disclosure
- Ongoing Disclosure Notices - Options, PSRs, Ordinary SharesInsider Disclosure
- Capital Change Notice - Issue of Ordinary SharesCapital Change
- Ongoing Disclosure Notices - Options, PSRs, Ordinary SharesInsider Disclosure
- Capital Change Notice - Issue of Performance Share RightsCapital Change
- Capital Change Notice - Issue of Employee Share RightsCapital Change
Fisher & Paykel Healthcare Corporation Limited (FPH) — frequently asked questions
What does Fisher & Paykel Healthcare Corporation Limited do?
Fisher & Paykel Healthcare designs, manufactures, and markets medical devices and systems for use in respiratory care, acute care, and the treatment of obstructive sleep apnea, selling to over 120 countries worldwide. Fisher & Paykel Healthcare Corporation Limited is listed on the NZX under the ticker FPH, in the Healthcare sector.
What is the Fisher & Paykel Healthcare Corporation Limited (FPH) share price?
Fisher & Paykel Healthcare Corporation Limited (NZX:FPH) shares closed at $49.43 on 21 October 2026, up 0.69% on the previous close. At that price its market capitalisation was about $29.08 billion, based on 588,265,424 shares on issue as at 1 October 2026.
Who are the directors of Fisher & Paykel Healthcare Corporation Limited?
Fisher & Paykel Healthcare Corporation Limited has 8 current directors: Neville Mitchell (Chair), Lewis Gradon (Executive Director), Lisa McIntyre (Non-Independent Director), Andrew Mark Cross (Independent Director), Michael Daniell (Independent Director), Graham McLean (Independent Director), Cather Simpson (Independent Director) and Anna Curzon (Director). Average board tenure is 5.5 years.
Who is the chair of Fisher & Paykel Healthcare Corporation Limited?
Neville Mitchell chairs the Fisher & Paykel Healthcare Corporation Limited board, and has been a director since 2018.
Who is the CEO of Fisher & Paykel Healthcare Corporation Limited?
Lewis Gradon is the Managing Director and Chief Executive Officer of Fisher & Paykel Healthcare Corporation Limited.
What was Fisher & Paykel Healthcare Corporation Limited's most recent dividend?
The most recent Fisher & Paykel Healthcare Corporation Limited dividend on record is 33.00 cents per share for FY2026 (final), 100% imputed, ex-dividend 22 June 2026, paid 3 July 2026.
What is Fisher & Paykel Healthcare Corporation Limited's dividend yield?
Fisher & Paykel Healthcare Corporation Limited's trailing 12-month dividend yield is 1.05%, as at 21 October 2026. That is 52.00 cents per share of ordinary dividends with an ex-date in the 12 months to 21 October 2026, divided by the 21 October 2026 closing price of $49.43. Special dividends are excluded.
Who are the largest shareholders of Fisher & Paykel Healthcare Corporation Limited?
The largest registered holder of FPH shares in the FY2024 top-20 register was HSBC Nominees (New Zealand) Limited R601127393, with 14.30%, followed by HSBC Nominees (New Zealand) Limited R60112738551 (8.88%) and JPMorgan Nominees Australia Pty Limited (8.33%). Custodians and nominees on the register hold shares on behalf of other investors.
What is Fisher & Paykel Healthcare Corporation Limited's governance score?
Fisher & Paykel Healthcare Corporation Limited has an NZXplorer Governance Risk Score of 84/100 (Excellent) for FY2026, based on 73% data coverage.
When was the last Fisher & Paykel Healthcare Corporation Limited annual meeting?
The most recent Fisher & Paykel Healthcare Corporation Limited annual meeting on record was held on 25 August 2026.
Healthcare companies on the NZX
Compare Fisher & Paykel Healthcare Corporation Limited with other NZX-listed healthcare companies.